Clinical and subclinical alveolitis in connective tissue diseases assessed by bronchoalveolar lavage

https://doi.org/10.1016/S0049-0172(97)80042-XGet rights and content

Abstract

Subclinical alveolitis, as assessed by bronchoalveolar lavage (BAL) cell analysis,may be present in the lower respiratory tract of a high proportion of symptom-less patients with connective tissue diseases (CTDs) with normal chest roentgenograms. The distribution of BAL cell types, mainly macrophages, lymphocytes, and polymorphonuclear neutrophils, varies according to type of CTD and to the presence of associated interstitial lung disease (ILD). Neverthe-less, subclinical alveolitis can be classified into two major groups: lymphocyte and neutrophil alveolitis. A mixed, lymphocyte and neutrophil alveolitis may be detected as well. Subclinical alveolitis, particularly in systemic sclerosis, frequently is associated with abnormalities of lung parenchyma as assessed by computed tomography (CT) scan, supporting the hypothesis that it may be associated with the development of overt ILD. Close follow-up of these patients is needed to better determine whether subclinical alveolitis precedes ILD and whether early detection of subclinical alveolitis in CTDs may identify those patients who are at risk for the development of ILD in the future.

References (94)

  • Turner-StokesL. et al.

    Intrathoracic manifestations of SLE

    Clin Rheum Dis

    (1982)
  • HochbergM.C. et al.

    Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature

    Semin Arthritis Rheum

    (1986)
  • BombardieriS. et al.

    Lung involvement in essential mixed cryoglobulinemia

    Am J Med

    (1979)
  • BertorelliG. et al.

    Sublinical pulmonary involvement in essential mixed cryoglobulinemia assessed by bronchoalveolar lavage

    Chest

    (1991)
  • HunninghakeG.W. et al.

    Pulmonary involvement in the collagen vascular diseases

    Am Rev Respir Dis

    (1979)
  • LynchJP et al.

    Pulmonary complications of collagen vascular disease

    Annu Rev Med

    (1992)
  • CrystalR.G. et al.

    Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts)

    N Engl J Med

    (1984)
  • ReynoldsH. et al.

    Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage

    J Lab Clin Med

    (1974)
  • WallaertB.

    Subclinical alveolitis in immunologic systemic disorders

    Lung

    (1990)
  • La CorteR. et al.

    Bronchial hyperreactivity in systemic sclerosis: influence of associated Sjögren's syndrome

    Ann Rheum Dis

    (1995)
  • GudbjörnssonB. et al.

    Bronchial hyperresponsiveness to methacoline in patients with primary Sjögren's syndrome

    Ann Rheum Dis

    (1991)
  • BariffiF. et al.

    Pulmonary involvement in Sjögren's syndrome

    Respiration

    (1984)
  • WallaertB. et al.

    Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage: relationship between alveolitis and subsequent changes in lung function

    Am Rev Respir Dis

    (1986)
  • SalaffiF. et al.

    Bronchoalveolar lavage in primary Sjögren's syndrome

    Eur J Intern Med

    (1995)
  • HatronP.Y. et al.

    Subclinical lung inflammation in primary Sjögren's syndrome: relationship between bronchoalveolar lavage cellular analysis findings andcharacteristics of the disease

    Arthritis Rheum

    (1987)
  • GardinerP. et al.

    Pleuropulmonary abnormalities in primary Sjögren's syndrome

    J Rheumatol

    (1993)
  • GudbjörnssonB. et al.

    Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome

    Ann Rheum Dis

    (1994)
  • WellsA.U. et al.

    Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis

    Am Rev Respir Dis

    (1994)
  • SilverR.M. et al.

    Interstitial lung disease in scleroderma: analysis by bronchoalveolar lavage

    Arthritis Rheum

    (1984)
  • EdelsonJ.D. et al.

    Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features

    J Rheumatol

    (1985)
  • RossiG.A. et al.

    Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis

    Am Rev Respir Dis

    (1985)
  • OwensG.R. et al.

    Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis

    J Lab Clin Med

    (1986)
  • WarrickJ.H. et al.

    High resolution computed tomography in early scleroderma lung disease

    J Rheumatol

    (1991)
  • Remy-JardinM. et al.

    Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage

    Radiology

    (1993)
  • WellsA.U. et al.

    Fibrosing alveolitis in systemic sclerosis: bronchoalveolar lavage findings in relation to computed tomographic appearance

    Am J Respir Crit Care Med

    (1994)
  • GustafssonR. et al.

    Eosinophil activation in systemic sclerosis

    Arthritis Rheum

    (1991)
  • ChanezP. et al.

    Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung

    Am Rev Respir Dis

    (1993)
  • PesciA. et al.

    Bronchoalveolar lavage analysis of interstitial lung disease in CREST syndrome

    Clin Exp Rheumatol

    (1986)
  • SalaffiF. et al.

    Lung inflammation in systemic sclerosis: evaluation by bronchoalveolar lavage

    Recent Prog Med

    (1994)
  • FrigeriL. et al.

    Bilateral bronchoalveolar lavage in progressive systemic sclerosis: interlobar variability, lymphocyte subpopulations, and functional correlations

    Respiration

    (1991)
  • MillerK.S. et al.

    Lung disease associated with progressive systemic sclerosis: assessment of interlobar variation by bronchoalveolar lavage and comparison withnoninvasive evaluation of disease activity

    Am Rev Respir Dis

    (1990)
  • SilverR.M. et al.

    Interstitial lung disease in scleroderma: immune complexes in sera and bronchoalveolar lavage fluid

    Arthritis Rheum

    (1986)
  • RennardS.I. et al.

    Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases

  • BittermanP.B. et al.

    Role of fibronectin as a growth factor for fibroblasts

    J Cell Biol

    (1983)
  • KinsellaM.B. et al.

    Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma

    Arthritis Rheum

    (1989)
  • LudwickaA. et al.

    Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma

    J Rheumatol

    (1992)
  • DeguchiY.

    Spontaneous increase of transforming growth factor β production by bronchoalveolar mononuclear cells of patients with systemic autoimmunediseases affecting the lung

    Ann Rheum Dis

    (1992)
  • Cited by (36)

    • Pleural and pulmonary involvement in systemic lupus erythematosus

      2011, Presse Medicale
      Citation Excerpt :

      Lung function findings vary from isolated decrease in DLCO, restrictive pattern, small airway disease to an obstructive pattern [66]. Analysis of bronchoalveloar lavage (BAL) fluid cells in SLE patients without respiratory symptoms have shown changes of subclinical alveolitis [67,68]. Corticosteroids and immunosuppressive drugs are routinely used to treat ILD in patients with SLE, although the effectiveness of these therapies has not been verified by controlled trials.

    • CRYOGLOBULINEMIA

      2006, Encyclopedia of Respiratory Medicine: Volume 1-4
    • Cryoglobulinemia

      2006, Encyclopedia of Respiratory Medicine, Four-Volume Set
    View all citing articles on Scopus
    View full text